Ades Alan A. 4
4 · Organogenesis Holdings Inc. · Filed Feb 16, 2021
Insider Transaction Report
Form 4
Ades Alan A.
Director10% Owner
Transactions
- Sale
Class A Common Stock
2021-02-11$3.25/sh−200,000$650,000→ 68,594,976 total
Footnotes (1)
- [F1]The reported securities sold were held directly by Alan A. Ades, who is a member of the Group (as defined below). On November 17, 2020, Mr. Ades purchased shares of Class A common stock of Organogenesis Holdings Inc. at a price of $3.25 per share, including (i) 100,000 shares purchased by Mr. Ades as agent for and for the benefit of one of his sons and (ii) 100,000 shares purchased by Mr. Ades as agent for and for the benefit of an entity that is managed by Mr. Ades' son-in-law. This Form 4 reflects the sales of such shares.